Product Description
Dacihal Injection is a potent chemotherapy medication used in the treatment of various cancers, including liver cancer and kidney cancer. With its active ingredient, dacarbazine, it works by interfering with the growth and spread of cancer cells in the body. Administered intravenously under medical supervision, Dacihal Injection targets cancer cells while minimizing damage to healthy tissues, offering patients a chance at remission and improved quality of life. Despite potential side effects, the benefits of Dacihal Injection in treating cancer outweigh the risks, providing hope and relief to patients and their loved ones.
Comprehensive Oncologic TherapyDacihal injection serves as a potent antineoplastic antibiotic, providing therapeutic benefits across a range of pediatric and adult malignancies such as Wilms' tumor and Ewing sarcoma. Its high purity and efficacy, comparable to international brands like Cosmegen, underline its suitability for specialized cancer treatment protocols.
Safety and Handling PrecautionsDue to its cytotoxic nature, Dacihal requires specific handling procedures to ensure user and patient safety. Hospital use is mandated, with administration strictly under medical supervision. To minimize health risks, special disposal measures and protection from light are necessary, particularly to avoid hazardous extravasation during intravenous use.
Simple Reconstitution and AdministrationEach vial of Dacihal is supplied in a convenient, single-dose form. Reconstitution with Sterile Water for Injection USP yields a solution with a pH of approximately 5.5-7.5. The odorless, lyophilized powder rapidly dissolves, enabling efficient preparation for intravenous infusion by qualified healthcare professionals.
FAQ's of Dacihal injection:
Q: What is the recommended process for preparing Dacihal injection for intravenous administration?
A: Dacihal injection must be reconstituted with Sterile Water for Injection USP according to the package insert. Always ensure aseptic technique and proper cytotoxic handling. Do not administer unless the solution is clear. The reconstituted product should be used immediately or as specified by local guidelines.
Q: How should Dacihal injection be stored before use?
A: Store Dacihal injection at 2C to 8C and protect it from light. Keep the single-dose vial in its carton until ready to use. Proper storage is necessary to maintain the product's potency and stability for up to 24 months from the date of manufacture.
Q: When should Dacihal injection be prescribed for cancer treatment?
A: Dacihal injection is indicated as part of antineoplastic regimens in certain malignancies, including Wilms' tumor, childhood rhabdomyosarcoma, metastatic nonseminomatous testicular cancer, gestational trophoblastic neoplasia, and Ewing sarcoma. Treatment decisions and dosing must be determined by a qualified oncologist.
Q: Where can Dacihal injection be obtained and who can administer it?
A: Dacihal injection is a Schedule H, prescription-only medicine, available through hospital pharmacies and oncology centers. It must only be administered by medical professionals, specifically those experienced in cytotoxic chemotherapy, within accredited healthcare facilities.
Q: What precautions should be taken during the administration and disposal of Dacihal injection?
A: Dacihal injection is a cytotoxic agent and should be handled with protective equipment to prevent exposure. All materials used for reconstitution, administration, and disposal must follow cytotoxic waste handling protocols. Extravasation during intravenous use is hazardous and must be avoided.
Q: What are the benefits of Dacihal injection for cancer patients?
A: Dacihal injection offers a well-established therapeutic benefit in the treatment of specific cancers, contributing to improved outcomes when included in standard oncologic protocols. Its precise dosage and high purity make it a valuable choice for managed hospital-based chemotherapy.